---
title: "Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289047958.md"
description: "Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock News"
datetime: "2026-06-08T03:30:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289047958.md)
  - [en](https://longbridge.com/en/news/289047958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289047958.md)
---

# Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock News

Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock News

### Related Stocks

- [SNGX.US](https://longbridge.com/en/quote/SNGX.US.md)

## Related News & Research

- [Soligenix raises at‑market share capacity by $2.956M under sales agreement](https://longbridge.com/en/news/287974515.md)
- [Regeneron (REGN) Stock Valuation After WHO Ebola Trial Backing And Expanding R&D Collaborations](https://longbridge.com/en/news/289661069.md)
- [FACTBOX-What Bundibugyo Ebola vaccines and treatments are under development](https://longbridge.com/en/news/289205985.md)
- [US urges Europe to impose Ebola travel bans ahead of World Cup](https://longbridge.com/en/news/289346480.md)
- [06:46 ETElsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak](https://longbridge.com/en/news/289585792.md)